E N D
1. Obsessive-compulsive disorder Symptoms
Neuropathology
Treatments
Causes
2. OCD Obsessions: persistent thoughts
Compulsions: persistent behaviors
Individual is aware that the behavior or obsession is unreasonable or excessive
5. Heterogeneity “folie du doute” (madness of doubt) and “delire du toucher” (delusion of touch) (Flaret, 1869)
Checkers vs. washers
Continuing challenge
6. OCD ONSET
males, childhood, often associated with tic disorders
Females, puberty and early adulthood
3.3 million adults in the United States (2-3 %)
Cross-cultural studies find symptoms are similar in various racial and ethnic groups
7. Associated Disorders Associated Disorders:
Trichotillomania
Onychophagia
Co-morbidity
Depression
Tourette’s
body dysmorphic disorder
Eating disorders
8. Neuropathology Imaging studies
Structural: increases or decreases in size of the orbitofrontal cortex, striatum, or thalamus
Increased activity in caudate, orbitofrontal cortex, cingulate cortex
Dysfunction of cortical/basal ganglia loop
Huntington’s, Tourette’s, maybe Parkinson’s, Sydenham’s chorea also exhibit OCD
Remember craving and compulsive drug-taking?
9. Structural alterations
10. Reduced left orbitofrontal cortex in OCD patients correlates with severity of symptoms
11. Alterations in the anterior cingulate and globus pallidus
12. Altered white matter in the anterior cingulate cortex
13. Altered function of the cortico-striatal-thalamo-cortical loop
14. Overactivity of prefrontal-basal ganglia loops
15. Increased activity in the thalamus
17. At rest: Increased activity of the orbitofrontal cortex
Increased activity of the cingulate cortex
Increased activity in the caudate nucleus
Increased activity in the thalamus
18. fMRI
“Contaminated” items vs neutral items
Handling of contaminated items exacerbated activity in the prefrontal cortical areas (anterior cingulate, orbitofrontal), the basal ganglia, and the amygdala Hyperactivity is exacerbated during symptom provocation
19. Activation in the orbitofrontal cortex and amygdala during symptom provocation
20. Subtypes of OCD Symmetry/ordering
Hoarding
Contamination/cleaning
Obsessions/checking
22. Washing
23. Checking
24. Hoarding
25. There may be distinct neural pathological patterns associated with different symptom dimensions Cleaning may be more related to emotional processing
Checking may be more related to dysfunction in attention and inhibitory control
26. Injury-induced OCD
27. Overactivity of cortico-basal ganglia Baseline
During provocation of symptoms
Specific pattern may depend on OCD type
OCD can be caused by damage to the basal ganglia
OCD occurs in other prefrontal-basal ganglia disorders
30. Alterations in other cognitive/emotional processes
31. Activation of the anterior cingulate when errors are committed on a cognitive task in OCD patients
32. Cognitive Alterations Memory (working, etc)
Set shifting
Response inhibition (more errors of commission)
33. Dysfunction of inhibitory processing
34. Altered Direct/Indirect Pathway Balance Overactivity of the DIRECT LOOP
35. Dysfunction of habit formation?
36. Neurochemical alterations
37. Serotonin hypothesis OCD is related to serotonin dysfunction
Pharmacological treatments for OCD
Clomipramine
Fluoxetine (Prozac)
Paroxetine (Paxil)
Serotonin Antagonists exacerbate symptoms
Data on serotonergic measures in OCD patients have been conflicting
38. Serotonin modulates the prefrontal cortex, striatum, and thalamus
39. Symptoms can be exacerbated by increasing 5-HT function
41. Evidence of 5-HT dysfunction Increased 5-HT2A receptors in caudate which are normalized after SSRI treatment (Adams et al., 2005, Int J Neuropsychopharmacol)
Alterations in serotonin transporters
42. Increased midbrain serotonin transporter binding sites
43. No difference in serotonin transporter binding
44. Reduced 5-HT transporters in midbrain
45. Dopamine Up to 40% of OCD patients do not respond to SSRIs.
Dopamine agonists induce stereotyped movement in humans and animals
Dopamine agonists can exacerbate OCD symptoms
Co-morbidity of Tourette’s and OCD (up to 90% of individuals with Tourette’s have OCD)
Adjunctive therapy with conventional antipsychotics add to reduction of OCD symptoms in individuals treated with SSRIs
46. Increases in striatal dopamine transporter binding in OCD patients
47. Increased striatal DA transporters in psychotropic-naďve OCD patients
48. Alterations in striatal D2 receptors
49. Treatments
50. Treatments SSRIs
Adjunctive antipsychotics (dopamine antagonists)
Behavior therapy
Psychosurgery
Effective treatment, pharmacologic or behavioral therapy, normalizes activity
51. Normalization of striatal activity with SSRI treatment
52. Normalization of orbitofrontal cortex activation
53. Behavioral treatment is effective
54. PET scans of OCD patients
55. Either drug treatment or behavioral treatment normalizes brain activity
56. Surgical treatments Destroy connections between the frontal lobe and basal ganglia/limbic structures
Cingulotomy
57. Psychosurgeries
59. Psychosurgery Success 27% definite improvement, 27% probably improvement, 46% no improvement (Baer et al, 1995)
32% definite improvement, 14% partial improvement, 54% no improvement (Dougherty et al, 2002)
60. Psychosurgeries
61. Can imaging help predict treatment efficacy?
62. Causes Genetics
Concordance rates are higher among monozygotic twins compared to dizygotic twins
First-degree relatives are 3-12 times more likely to develop OCD
Streptococcal infection: immune reaction
63. Genetic targets Polymorphism in the promoter region for the serotonergic reuptake transporter
5-HT 1D receptor gene
DRD4 receptor mutations
64. PANDAs Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
65. Case of Frances
66. Summary OCD is related to dysfunction of prefrontal-basal ganglia loops that lead to repetitive thoughts and actions
Effective treatments normalize this activity
Treatments include SSRIs, behavioral therapies and psychosurgery
Causes include genetic factors and possible autoimmune reactions